Safely Reduce Cystoscopic Evaluations for Hematuria Patients
Recruiting
N/A
Interventional Study
Hematuria
Urothelial Neoplasm
Urothelial Carcinoma
Bladder Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 1,100 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The SeARCH-trial assess the clinical impact of a molecular urine test as a 'urine-first' strategy in the diagnostic workup of patients presenting with microscopic hematuria.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Microscopically confirmed microscopic hematuria of voided urine defined as ≥3 erythrocytes per high power field
* Male patients ≥40 years
* Female patients ≥50 years
Exclusion Criteria:
* History of urothelial bladder- or urinary tract cancer
* Presence of macroscopic (visib…
Contacts
No contact information available.